Conformational Changes of G Protein‐Coupled Receptors During Their Activation by Agonist Binding

References

• Flower D. R. Modelling G‐protein‐coupled receptors for drug design. Biochim Biophys Acta 1999; 1422(3)207–234
   Google Scholar
• Schwartz T. W. Locating ligand‐binding sites in 7TM receptors by protein engineering. Curr Opin Biotech 1994; 5(4)434–444
   Google Scholar
• Franke R. R., Konig B., Sakmar T. P., Khorana H. G., Hofmann K. P. Rhodopsin mutants that bind but fail to activate transducin. Science 1990; 250(4977)123–125
   Google Scholar
• Franke R. R., Sakmar T. P., Graham R. M., Khorana H. G. Structure and function in rhodopsin. J Biol Chem 1992; 267(21)14767–14774
   Google Scholar
• Marin E. P., Krishna A. G., Zvyaga T. A., Isele J., Siebert F., Sakmar T. P. The amino terminus of the fourth cytoplasmic loop of rhodopsin modulates rhodopsin‐transducin interaction. J Biol Chem 2000; 275(3)1930–1936
   Google Scholar
• Ernst O. P., Meyer C. K., Marin E. P., Henklein P., Fu W. Y., Sakmar T. P., Hofmann K. P. Mutation of the fourth cytoplasmic loop of rhodopsin affects binding of transducin and peptides derived from the carboxyl‐terminal sequences of transducin α and γ subunits. J Biol Chem 2000; 275(3)1937–1943
   Google Scholar
• Hamm H. The many faces of G protein signaling. J Biol Chem 1998; 273(2)669–672
   Web of Science ®Google Scholar
• Lefkowitz R. J. G Protein‐coupled receptors III. New roles for receptor kinases and β‐arrestins in receptor signaling and desensitization. J Biol Chem 1998; 273(30)18677–18680
   Google Scholar
• Luttrell L. M., Ferguson S. S.G., Daaka Y., Miller W. E., Maudsley S., Della Rocca G. J., Lin F. T., Kawakatsu H., Owada K., Luttrell D. K., Caron M. G., Lefkowitz R. J. β‐arrestin‐dependent formation of β2‐adrenergic receptor‐Src protein kinase complexes. Science 1999; 283(5402)655–661
   PubMed Web of Science ®Google Scholar
• Hall R. A., Premont R. T., Chow C. W., Blitzer J. T., Pitcher J. A., Claing A., Stoffel R. H., Barak L. S., Shenolikar S., Weinman E. J., Grinstein S., Lefkowitz R. J. The β2‐adrenergic receptor interacts with the Na+/H+ exchanger regulatory factor to control Na+/H+ exchange. Nature 1998; 392(6676)626–630
   Google Scholar
• Brakeman P., Lanahan A. A., O'Brien R., Roche K., Barnes C. A., Huganir R. L., Worley P. F. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 1997; 386(6622)284–288
   PubMed Web of Science ®Google Scholar
• Lefkowitz R. J., Pitcher J., Krueger K., Daaka Y. Mechanisms of β‐adrenergic receptor desensitization and resensitization. Adv Pharmacol 1998; 42: 416–420
   PubMedGoogle Scholar
• Horn F., Weare J., Beukers M. W., Hörsch S., Bairoch A., Chen W., Edvardsen Ø., Campagne F., Vriend G. GPCRDB: an information system for G protein‐coupled receptors. Nucleic Acids Res 1998; 26(1)277–281
   Google Scholar
• Ji T. H., Grossmann M., Ji I. G protein‐coupled receptors I. Diversity of receptor‐ligand interactions. J Biol Chem 1998; 273(28)17299–17302
   PubMed Web of Science ®Google Scholar
• Henderson R., Baldwin J. M., Ceska T. A., Zemlin F., Beckmann E., Downing K. H. Model for the structure of bacteriorhodopsin based on high‐resolution electron cryomicroscopy. J Mol Biol 1990; 213(4)899–929
   PubMed Web of Science ®Google Scholar
• Hibert M. F., Trumpp‐Kallmeyer S., Bruinvels A., Hoflack J. Three‐dimensional models of neurotransmitter G‐binding protein‐coupled receptors. Mol Pharmacol 1991; 40(1)8–15
   PubMedGoogle Scholar
• Baldwin J. M. The probable arrangement of the helices in G protein‐coupled receptors. EMBO J 1993; 12(4)1693–1703
   Google Scholar
• Schertler G. F.X., Villa C., Henderson R. Projection structure of rhodopsin. Nature 1993; 362(6422)770–772
   Google Scholar
• Unger V. M., Hargrave P. A., Baldwin J. M., Schertler G. F.X. Arrangement of rhodopsin transmembrane alpha helices obtained by electron cryo‐microscopy. Nature 1997; 389(6647)203–206
   Google Scholar
• Baldwin J. M., Schertler G. F.X., Unger V. M. An alpha‐carbon template for the transmembrane helices in the rhodopsin family of G‐protein‐coupled receptors. J Mol Biol 1997; 272(1)144–164
   Google Scholar
• Palczewski K., Kumasaka T., Hori T., Behnke C. A., Motoshima H., Fox B. A., Le Trong I., Teller D. C., Okada T., Stenkamk R. E., Yamamoto M., Miyano M. Crystal structure of rhodopsin: a G protein‐coupled receptor. Science 2000; 289(5480)739–745
   PubMed Web of Science ®Google Scholar
• Teller D. C., Okada T., Behnke C. A., Palczewski K., Stenkamp R. E. Advances in determination of a high‐resolution three‐dimensional structure of rhodopsin, a model of G‐protein‐coupled receptors (GPCRs). Biochemistry 2001; 40(26)7761–7772
   Google Scholar
• Okada T., Fujiyoshi Y., Silow M., Navarro J., Landau E. M., Shichida Y. Functional role of internal water in rhodopsin revealed by x‐ray crystallography. Proc Natl Acad Sci USA 2002; 99(9)5982–5987
   Google Scholar
• Singh D., Hudson B. S., Middleton C., Birge R. R. Conformation and orientation of the retinyl chromophore in rhodopsin: a critical evaluation of recent NMR data on the basis of theoretical calculation results in a minimum energy consistent with all experimental data. Biochemistry 2001; 40(14)4201–4204
   Google Scholar
• Fotiadis D., Liang Y., Filipek S., Saperstein D. A., Engel A., Palczewski K. Rhodopsin dimers in native disc membranes. Nature 2003; 421(6919)127–128
   PubMed Web of Science ®Google Scholar
• Borhan B., Souto M. L., Imai H., Shichida Y., Nakanishi K. Movement of retinal along the visual transduction path. Science 2000; 288(5474)2209–2212
   Google Scholar
• Jäger F., Fahmy K., Sakmar T. P., Siebert F. Identification of glutamic acid 113 as the Schiff base proton acceptor in the metarhodopsin II photointermediate of rhodopsin. Biochemistry 1994; 33(36)10878–10882
   Google Scholar
• Arnis S., Fahmy K., Hofmann K. P., Sakmar T. P. A conserved carboxylic acid group mediates light‐dependent proton uptake and signaling by rhodopsin. J Biol Chem 1994; 269(39)23879–23881
   Google Scholar
• Arnis S., Hofmann K. P. Two different forms of metarhodopsin II: Schiff base deprotonation precedes proton uptake and signaling state. Proc Natl Acad Sci USA 1993; 90(16)7849–7853
   Google Scholar
• Meyer C. K., Böhme M., Ockenfels A., Gärtner W., Hofmann K. P., Ernst O. Signaling states of rhodopsin. J Biol Chem 2000; 275(26)19713–19718
   Google Scholar
• Jang G., Kuksa V., Filipek S., Bartl F., Ritter E., Gelb M. H., Hofmann K. P., Palczewski K. Mechanism of rhodopsin activation as examined with ring‐constrained retinal analogs and the crystal structure of the ground state protein. J Biol Chem 2001; 276(28)26148–26153
   Google Scholar
• Kuksa V., Bartl F., Maeda T., Jang G., Ritter E., Heck M., Van Hooser J. P., Liang Y., Filipek S., Gelb M. H., Hofmann K. P., Palczewski K. Biochemical and physiological properties of rhodopsin regenerated with 11‐cis‐6‐ring‐ and 7‐ring‐retinals. J Biol Chem 2002; 277(44)42315–42324
   Google Scholar
• Lin S. W., Sakmar T. P. Specific tryptophan UV‐absorbance changes are probes of the transition of rhodopsin to its active state. Biochemistry 1996; 35(34)11149–11159
   Google Scholar
• Altenbach C., Klein‐Seetharaman J., Hwa J., Khorana H. G., Hubbell W. L. Structural features and light‐dependent changes in the sequence 59‐75 connecting helices I and II in rhodopsin: a site‐directed spin‐labeling study. Biochemistry 1999; 38(25)7945–7949
   Google Scholar
• Farahbakhsh Z. T., Ridge K. D., Khorana H. G., Hubbell W. L. Mapping light‐dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site‐directed spin‐labeling study. Biochemistry 1995; 34(27)8812–8819
   Google Scholar
• Altenbach C., Yang K., Farrnes D. L., Farahbakhsh Z. T., Khorana H. G., Hubbell W. L. Structural features and light‐dependent changes in the cytoplasmic interhelical E‐F loop region of rhodopsin: a site‐directed spin‐labeling study. Biochemistry 1996; 35(38)12470–12478
   Google Scholar
• Farrens D. L., Altenbach C., Yang K., Hubbell W. L., Khorana H. G. Requirement of rigid‐body motion of transmembrane helices for light activation of rhodopsin. Science 1996; 274(5288)768–770
   PubMed Web of Science ®Google Scholar
• Dunham T. D., Farrens D. L. Conformational changes in rhodopsin. J Biol Chem 1999; 274(3)1683–1690
   Google Scholar
• Cai K., Klein‐Seetharaman J., Hwa J., Hubbell W. L., Khorana H. G. Structure and function in rhodopsin: effects of disulfide cross‐links in the cytoplasmic face of rhodopsin on transducins activation and phosphorylation by rhodopsin kinase. Biochemistry 1999; 38(39)12893–12898
   Google Scholar
• Sheikh S. P., Zvyaga T. A., Lichtarge T. P., Sakmar P., Bourne H. R. Rhodopsin activation blocked by metal‐ion‐binding sites linking transmembrane helices C and F. Nature 1996; 383(6598)347–350
   Google Scholar
• Altenbach C., Cai K., Klein‐Seetharaman J., Khorana H. G., Hubbell W. L. Structure and function in rhodopsin: mapping light‐dependent changes in distance between residue 65 in helix TM1 and residues in the sequence 306–319 at the cytoplasmic end of helix TM7 and in helix H8. Biochemistry 2001; 40(51)15483–15492
   Google Scholar
• Altenbach C., Klein‐Seetharaman J., Cai K., Khorana H. G., Hubbell W. L. Structure and function in rhodopsin: mapping light‐dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60‐75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1. Biochemistry 2001; 40(51)15493–15500
   Google Scholar
• Abdulaev N., Ridge K. D. Light induced exposure of the cytoplasmic end of transmembrane helix seven in rhodopsin. Proc Natl Acad Sci USA 1998; 95(22)12854–12859
   Google Scholar
• Krishna A. G., Menon S. T., Terry T. J., Sakmar T. P. Evidence that helix 8 of rhodopsin acts as a membrane‐dependent conformational switch. Biochemistry 2002; 41(26)8298–8309
   Google Scholar
• Gether U., Lin S., Kobilka B. K. Fluorescent labeling of purified β2‐adrenergic receptor. J Biol Chem 1995; 270(47)28268–28275
   PubMedGoogle Scholar
• Gether U., Lin S., Ghanouni P., Ballesteros J. A., Weinstein H., Kobilka B. K. Agonists induce conformational changes in transmembrane domains III and VI of the β2‐adrenoceptor. EMBO J 1997; 16(22)6737–6747
   Google Scholar
• Jensen A. D., Guarnieri F., Rasmussen S. G.F., Asmar F., Ballesteros J. A., Gether U. Agonist‐induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the β2‐adrenergic receptor mapped by site‐selective fluorescent labeling. J Biol Chem 2001; 276(12)9279–9290
   Google Scholar
• Ghanouni G., Steenhuis J. J., Farrens D. L., Kobilka B. K. Agonist‐induced conformational changes in the G‐protein‐coupling domain of the β2 adrenergic receptor. Proc Natl Acad Sci USA 2001; 98(11)5997–6002
   Google Scholar
• Sheikh S. P., Vilardarga J., Baranski T. J., Lichtarge O., Iiri T., Meng E. C., Nissenson R. A., Bourne H. R. Similar structures and shared switch mechanism of the β2‐adrenoceptor and the parathyroid hormone receptor. J Biol Chem 1999; 274(24)17033–17041
   Google Scholar
• Ward S. D.C., Hamdan F. F., Bloodworth L. M., Wess J. Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross‐linking strategy. J Biol Chem 2002; 277(3)2247–2257
   Google Scholar
• Struthers M., Yu H., Kono M., Oprian D. D. Tertiary interactions between the fifth and sixth transmembrane segments of rhodopsin. Biochemistry 1999; 38(20)6597–6603
   Google Scholar
• Struthers M., Yu H., Oprian D. D. G protein‐coupled receptor activation: analysis of a highly constrained, “straitjacketed” rhodopsin. Biochemistry 2000; 39(27)7938–7942
   Google Scholar
• Cohen G. B., Yang T., Robinson P. R., Oprian D. D. Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry 1993; 32(23)6111–6115
   Google Scholar
• Rasmussen S. G.G., Jensen A. D., Liapakis G., Ghanouni P., Javitch J. A., Gether U. Mutation of a highly conserved aspartic acid in the β2 adrenergic receptor: constitutive activity, structural instability, and conformational rearrangement of transmembrane segment 6. Mol Pharmacol 1999; 56(1)175–184
   Google Scholar
• Alewijnse A. E., Timmerman H., Jacobs E. H., Smit M. J., Roovers E., Cotecchia S., Leurs R. The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H2 receptor. Mol Pharmacol 2000; 57(5)890–898
   Google Scholar
• Scheer A., Fanelli F., Costa T., De Benedetti P. G., Cotecchia S. The activation process of the α1B‐adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 1997; 94(3)808–813
   Google Scholar
• Gether U., Ballesteros J. A., Seifert R., Sanders‐Bush E., Weinstein H., Kobilka B. K. Structural instability of a constitutively active G protein‐coupled receptor. J Biol Chem 1997; 272(5)2587–2590
   Google Scholar
• Kim J., Altenbach C., Thurmond R. L., Khorana H. G., Hubbell W. L. Structure and function in rhodopsin: rhodopsin mutants with a neutral amino acid at E134 have a partially activated conformation in the dark state. Proc Natl Acad Sci USA 1997; 94(26)14273–14278
   Google Scholar
• Ghanouni P., Schambye H., Seifert R., Lee T. W., Rasmussen S. G.F., Gether U., Kobilka B. K. The effect of pH on β2 adrenoceptor function. J Biol Chem 2000; 275(5)3121–3127
   Google Scholar
• Ballesteros J., Kitanovic S., Guarnieri F., Davies P., Fromme B. J., Konvicka K., Chi L., Millar R. P., Davidson J. S., Weinstein H., Sealfon S. C. Functional microdomain in G‐protein‐coupled receptors. J Biol Chem 1998; 273(17)10445–10453
   Google Scholar
• Ballesteros J., Jensen A. D., Liapakis G., Rasmussen S. G.F., Shi L., Gether U., Javitch J. A. Activation of the β2‐adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 2001; 276(31)29171–29177
   Google Scholar
• Greasley P. J., Fanelli F., Rossier O., Abuin L., Cotecchia S. Mutategensis and modeling of the α1B‐adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol Pharmacol 2002; 61(5)1025–1032
   Google Scholar
• Shapiro D. A., Kristiansen K., Weiner D. M., Kroeze W. K., Roth B. L. Evidence for a model of agonist‐induced activation of 5‐hydroxytryptamine 2A serotonin receptors that involve the disruption of a strong ionic interaction between helices 3 and 6. J Biol Chem 2002; 277(13)11441–11449
   Google Scholar
• Huang P., Li J., Chen C., Visiers I., Weinstein H., Liu‐Chen L. Y. Functional role of a conserved motif in TM6 of the rat μ opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. Biochemistry 2001; 40(45)13501–13509
   Google Scholar
• Huang P., Visiers I., Liu‐Chen L. Y. The local environment at the cytoplasmic end of TM6 of the μ opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the μ opioid receptor and reduces constitutive activity of its T6.34(279)K mutant. Biochemistry 2002; 41(40)11972–11980
   Google Scholar
• Robinson P. R., Cohen G. B., Zhukovsky E. A., Oprian D. D. Constitutively actively mutants of rhodopsin. Neuron 1992; 9(4)719–725
   Google Scholar
• Befort K., Zilliox C., Fillio D., Yue S., Kieffer B. L. Constitutive activation of the δ opioid receptor by mutations in transmembrane domains III and VII. J Biol Chem 1999; 274(26)18574–18581
   Google Scholar
• Porter J. E., Hwa J., Perez D. M. Activation of the α1B‐adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. J Biol Chem 1996; 271(45)28318–28323
   Google Scholar
• Groblewski T., Maigret B., Larguir R., Lombard C., Bonnafous J., Marie J. Mutation of Asn111 in the third transmembrane domain of the AT1a angiotensin II receptor induces its constitutive activation. J Biol Chem 1997; 272(3)1822–1826
   Google Scholar
• Han M., Smith S. O., Sakmar T. P. Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6. Biochemistry 1998; 37(22)8253–8261
   Google Scholar
• Fritze O., Filipek S., Kuksa V., Palczewski K., Hofmann K. P., Ernst O. P. Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc Natl Acad Sci USA 2003; 100(5)2290–2295
   Google Scholar
• Zhou W., Flanagan C., Ballesteros J. A., Konvicka K., Davidson J. S., Weinstein H., Millar R. P., Sealfon S. C. A reciprocal mutation supports helix 2 and 7 proximity in the gonatropin‐releasing hormone receptor. Mol Pharmacol 1994; 45(2)165–170
   Google Scholar
• Sealfon S. C., Chi L., Ebersole B. J., Rodic V., Zhang D., Ballesteros J. A., Weinstein H. Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5‐HT2A receptor. J Biol Chem 1995; 270(28)16683–16688
   Google Scholar
• Perlman J. H., Colson A. O., Wang W., Bence K., Osman R., Gershengorn M. C. Interactions between conserved residues in transmembrane helices 1, 2 and 7 of the thyrotropin‐releasing hormone receptor. J Biol Chem 1997; 272(18)11937–11942
   Google Scholar
• Donnelly D., Maudsley S., Gent J. P., Moser R. N., Hurrell C. R., Findlay J. B.C. Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications. Biochem J 1999; 339(PT1)55–61
   Google Scholar
• Munshi U. M., Pogozheva I. D., Menon K. M.J. Highly conserved serine in the third transmembrane helix of the luteinizing hormone/human chorionic gonadotropin receptor regulates receptor activation. Biochemistry 2003; 42(13)3708–3715
   Google Scholar
• Shi L., Liapakis G., Xu R., Guarnieri F., Ballesteros J. A., Javitch J. A. β2‐adrenergic receptor activation. J Biol Chem 2002; 277(43)40989–40996
   Google Scholar
• Ebersole B. J., Visiers I., Weinstein H., Sealfon S. C. Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5‐HT2A receptor determines relative efficacy. Mol Pharmacol 2003; 63(1)36–43
   Google Scholar
• Farahbakhsh Z. T., Hideg K., Hubbell W. L. Photoactivated conformational changes in rhodopsin: a time‐resolved spin label study. Science 1993; 262(5138)1416–1419
   Google Scholar
• Heck M., Schädel S. A., Maretzki D., Bartl F. J., Ritter E., Palczewski K., Hofmann K. P. Signaling states of rhodopsin. J Biol Chem 2003; 278(5)3162–3169
   Google Scholar
• Gether U., Kobilka B. K. G protein‐coupled receptors II. Mechanism of agonist activation. J Biol Chem 1998; 273(29)17979–17982
   PubMed Web of Science ®Google Scholar
• Peleg G., Ghanouni P., Kobilka B. K., Zare R. N. Single‐molecule spectroscopy of the β2 adrenergic receptor: observation of conformational substates in a membrane protein. Proc Natl Acad Sci USA 2001; 98(15)8469–8474
   Google Scholar
• Ghanouni P., Gryczynski Z., Steenhuis J. J., Lee T. W., Farrens D. L., Lakowicz J. R., Kobilka B. K. Functionally different agonists induce distinct conformations in the G protein coupling domain of the β2 adrenergic receptor. J Biol Chem 2001; 276(27)24433–24436
   PubMed Web of Science ®Google Scholar
• Rios C. D., Jordan B. A., Gomes I., Devi L. A. G‐protein‐coupled receptor dimerization: modulation of receptor function. Pharmacol Therapeut 2001; 92(2–3)71–87
   Google Scholar
• Angers S., Salahpour A., Bouvier M. Dimerization: an emerging concept for G protein‐coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 2002; 42: 409–435
   PubMed Web of Science ®Google Scholar
• Ng G. Y., O'Dowd B. F., Lee S. P., Chung H. T., Brann M. R., Seeman P., George S. R. Dopamine D2 receptor dimers and receptor‐blocking peptides. Biochem Biophys Res Commun 1996; 227: 200–204
   PubMed Web of Science ®Google Scholar
• Romano S., Yang W. L., O'Malley K. L. Metobotropic glutamate receptor 5 is a disulfide‐linker dimer. J Biol Chem 1996; 271(45)28612–28616
   PubMed Web of Science ®Google Scholar
• Cvejic S., Devi L. A. Dimerization of the δ opioid receptor: implication for a role in receptor internalization. J Biol Chem 1997; 272(43)26959–26964
   PubMed Web of Science ®Google Scholar
• McVey M., Kellet E., Rees S., Wilson S., Pope A. J., Milligan G. Monitoring receptor oligomerization using time‐resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: the human δ‐opioid receptor displays constitutive oligomerization at the cell surface which is not regulated by receptor occupancy. J Biol Chem 2001; 276(17)14092–14099
   Google Scholar
• Bai M., Trivedi S., Brown E. M. Dimerization of the extracellular calcium‐sensing receptor (CaR) on the cell surface of caR‐transfected HEK293 cells. J Biol Chem 1998; 273(36)23605–23610
   Google Scholar
• Zeng F. Y., Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem 1999; 274(27)19487–19497
   PubMed Web of Science ®Google Scholar
• Angers S., Salahpour A., Joly E., Hilairet S., Chelsky D., Dennis M., Bouvier M. Detection of β2‐adrenergic receptor dimerization in living cells using bio‐ luminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 2000; 97(7)3684–3689
   PubMed Web of Science ®Google Scholar
• Hebert T. E., Moffett S., Morello J. P., Loisel T. P., Bichet D. G., Barret C., Bouvier M. A peptide derived from a β2‐adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 1996; 271(27)16384–16392
   PubMed Web of Science ®Google Scholar
• Kroeger K. M., Hanyaloglu A. C., Seeber R. M., Miles L., Eidne K. A. Constitutive and agonist‐dependent homooligomerization of the thyrotropin‐releasing hormone receptor; detection in living cells using bioluminescence resonance energy transfer. J Biol Chem 2001; 276(16)12736–12743
   Google Scholar
• Cornea A., Janovick J. A., Maya‐Nunez G., Conn P. M. Gonadotropin releasing hormone microaggregation: rate monitored by fluorescence resonance energy transfer. J Biol Chem 2001; 276(3)2153–2158
   Google Scholar
• Horvat R. D., Roess D. A., Nelson S. E., Barisas B. G., Clay C. M. Binding of agonist but not antagonist leads to fluorescence resonance energy transfer between intrinsically fluorescent gonadotropin releasing hormone receptors. Mol Endocrinol 2001; 15(5)695–703
   Google Scholar
• White J. H., Wise A., Main M. J., Green A., Fraser N. J., Disney G. H., Barnes A. A., Emson P., Foord S. M., Marshall F. H. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 1998; 396(6712)679–682
   PubMed Web of Science ®Google Scholar
• Jones K. A., Borowsky B., Tamm J. A., Craig D. A., Durkin M. M., Dai M., Yao W. J., Johnson M., Gunwaldsen C., Huang L. Y., Tang C., Shen Q., Salon J. A., Morse K., Laz T., Smith K. E., Nagarathnam D., Noble S. A., Branchek T. A., Gerald C. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998; 396(6712)674–679
   PubMedGoogle Scholar
• Kaupmann K., Malitschek B., Schuler V., Heid J., Froestl W., Beck P., Mosbacher J., Bischoff S., Kulik A., Shigemoto R., Karschin A., Bettler B. GABA(B) receptor subtypes assemble into functional heteromeric complexes. Nature 1998; 396(6712)683–687
   Web of Science ®Google Scholar
• Kuner R., Kohr G., Grunewald S., Eisenhardt G., Bach A., Kornau H. C. Role of heteromer formation in GABAB receptor function. Science 1999; 283(5398)74–77
   Google Scholar
• Jordan B. A., Devi L. A. G‐protein‐coupled receptor heterodimerization modulates receptor function. Nature 1999; 399(6737)697–700
   PubMed Web of Science ®Google Scholar
• Gomes I., Jordan B. A., Gupta A., Trapaidze N., Nagy V., Devi L. A. Heterodimerization of μ and δ opioid receptors: a role in opiate synergy. J Neurosci 2000; 20(22)RC110
   PubMed Web of Science ®Google Scholar
• Pfeiffer M., Koch T., Schroder H., Klutzny M., Kirscht S., Kreienkamp H. J., Höllt V., Schulz S. Homo‐ and heterodimerization of somatostatin receptor subtypes. Inactivation of sst3 receptor function by heterodimerization with sst2A. J Biol Chem 2001; 276(17)14027–14036
   Google Scholar
• Gines S., Hillion J., Torvinen M., Le Crom S., Casado V., Canela E. I., Rondin S., Lew J. Y., Watson S., Zoli M., Agnati L. F., Vernierá P., Luis C., Ferré S., Fuxe K., Franco R. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 2000; 97(15)8606–8611
   PubMed Web of Science ®Google Scholar
• Abdalla S., Lother H., Quitterer U. AT1‐receptor heterodimers show enhanced G‐protein activation and altered receptor sequestration. Nature 2000; 407(6800)94–98
   PubMed Web of Science ®Google Scholar
• Jordan B. A., Trapaidze N., Gomes I., Nivarthi R., Devi L. A. Oligomerization of opioid receptors with beta 2‐adrenergic receptors: a role in trafficking and mitogen‐activated protein kinase activation. Proc Natl Acad Sci USA 2001; 98(1)343–348
   Google Scholar
• Rocheville M., Lange D. C., Kumar U., Patel S. C., Patel R. C., Patel Y. C. Receptors for dopamine and somatostatin: formation of hetero‐oligomers with enhanced functional activity. Science 2000; 288(5463)154–157
   PubMed Web of Science ®Google Scholar
• Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H., Morokawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000; 407(6807)971–977
   PubMed Web of Science ®Google Scholar
• Sullivan R., Chateauneuf A., Coulombe N., Kolakowski L. F., Johnson M., Hebert T. E., Ethier N., Belle M., Metters K., Abramovitz G. P., O'Neill G. P., Ng G. Y. Co‐expression of full length γ‐aminobutyric acid B (GABAB) receptors with truncated receptors and metabotropic glutamate receptor 4 supports the GABAB heterodimer as the functional receptor. J Pharmacol Exp Ther 2000; 293(2)460–467
   Google Scholar
• Klabunde T., Hessler G. Drug design strategies for targeting G‐protein‐coupled receptors. Chem Bio Chem 2002; 3(10)928–944
   Google Scholar
• Visiers I., Ballesteros J. A., Weinstein H. Three‐dimensional representations of G protein‐coupled receptor structures and mechanisms. Methods Enzymol 2002; 343: 329–371
   PubMed Web of Science ®Google Scholar
• Shacham S., Topf M., Avisar N., Glaser F., Marantz Y., Bar‐Haim S., Noiman S., Naor Z., Becker O. M. Modeling the 3D structure of GPCRs from sequence. Med Res Rev 2001; 21(5)472–483
   Google Scholar
• Vaidehi N., Floriano W. B., Trabanino R., Hall S. E., Freddolino P., Choi E. J., Zamanakos G., Goddard W. A., III. Prediction of structure and function of G protein‐coupled receptors. Proc Natl Acad Sci USA 2002; 99(20)12622–12627
   PubMed Web of Science ®Google Scholar
• Hibert M. F., Trumpp‐Kallmeyer S., Bruinvels A., Hoflack J. Three‐dimensional models of neurotransmitter G‐binding protein‐coupled receptors. Mol Pharmacol 1991; 40(1)8–15
   PubMedGoogle Scholar
• Trumpp‐Kallmeyer S., Hoflack J., Bruinvels A., Hibert M. Modeling of G‐protein‐coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J Med Chem 1992; 35(19)3448–3462
   PubMedGoogle Scholar
• Cho W., Taylor L. P., Mansour A., Akil H. Hydrophobic residues of the D2 dopamine receptor are important for binding and signal transduction. J Neurochem 1995; 65(5)2105–2115
   Google Scholar
• Matsui H., Lazerno S., Birdsall N. J.M. Probing the location of the allosteric site on m1 muscarinic receptors by site‐directed mutagenesis. Mol Pharmacol 1995; 47(1)88–98
   Google Scholar
• Bourdon H., Trumpp‐Kallmeyer S., Schreuder H., Hoflack J., Hibert M., Wermuth C. G. Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement. J Comp‐Aided Mol Des 1997; 11(14)317–332
   Google Scholar
• Choudary M. S., Sachs N., Uluer R. A., Glennon R. B., Westkaemper R. B., Roth B. L. Different ergoline and ergopeptine binding to 5‐HT2a receptors: ergolines require an aromatic residue at position 340 for high affinity binding. Mol Pharmacol 1995; 47(3)450–457
   Google Scholar
• Roth B. L., Shoham M., Choudary M. S., Khan N. Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5‐hydroxytryptamine 2a receptors. Mol Pharmacol 1997; 52(2)259–266
   PubMed Web of Science ®Google Scholar
• Ballesteros J. A., Shi L., Javitch J. A. Structural mimicry in G protein‐coupled receptors: implications of the high‐resolution structure of rhodopsin for structure‐function analysis of rhodopsin‐like receptors. Mol Pharmacol 2001; 60(1)1–19
   Google Scholar
• Mouillac B., Chini B., Balestre M. N., Elands J., Trumpp‐Kallmeyer S., Hoflack J., Hibert M., Jard S., Barberis C. The binding site of neuropeptide vasopressin V1a receptor. J Biol Chem 1995; 270(43)25771–25777
   PubMed Web of Science ®Google Scholar
• Chini B., Mouillac B., Ala Y., Balestre M. N., Trumpp‐Kallmeyer S., Hoflack J., Elands J., Hibert M., Manning M., Jard S., Barberis C. EMBO J 1995; 14(10)2176–2182
   Google Scholar
• Cotte N., Balestre M. N., Aumelas A., Mahé E., Phalipou S., Morin D., Hibert M., Manning M., Durroux T., Barberis C., Mouillac B. Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding. Eur J Biochem 2000; 267(13)4253–4263
   Google Scholar
• Stenkamp R. E., Filipek S., Driessen C. A.G.G., Teller D. C., Palczewski K. Crystal structure of rhodopsin: a template for cone visual pigments and other G protein‐coupled receptors. Biochim Biophys Acta 2002; 1565(2)168–182
   Google Scholar
• Bissantz C., Bernard P., Hibert M., Rognan D. Protein‐based virtual screening of chemical databases. 2. Are homology models of G‐protein coupled receptors suitable targets?. Proteins 2003; 50(1)5–25
   Google Scholar
• Bissantz C., Folkers G., Rognan D. Protein‐based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J Med Chem 2000; 43(25)4759–4767
   PubMed Web of Science ®Google Scholar
• Forbes I. T., Dabbs S., Duckworth D. M., Ham P., Jones G. E., King F. D., Saunders D. V., Blaney F. E., Naylor C. B., Baxter G. S., Blackburn T. P., Kennett G. A., Wood M. D. Synthesis, biological activity, and molecular modeling studies of selective 5‐HT2C/2B receptor antagonists. J Med Chem 1996; 39(25)4966–4977
   Google Scholar
• Bromidge S. M., Dabbs S., Davies D. T., Duckworth D. M., Forbes I. T., Ham P., Jones G. E., King F. D., Saunders D. V., Starr S., Thewlis K. M., Wyman P. A., Blaney F. E., Naylor C. B., Bailey F., Blackburn T. P., Holland V., Kennett G. A., Riley G. J., Wood M. D. Novel and selective 5‐HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure‐activity relationships, and molecular modeling of substituted 1‐(3‐pyridylcarbamoyl)indolines. J Med Chem 1998; 41(10)1598–1612
   Google Scholar